Stocks and Investing
Stocks and Investing
Wed, August 4, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CC) at Buy with Increased Target to $40 on, Aug 3rd, 2021
Arun Viswanathan of RBC Capital, Maintained "The Chemours Company" (CC) at Buy with Increased Target from $35 to $40 on, Aug 3rd, 2021.
Arun has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 1 agrees with Arun's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Monday, May 10th, 2021
These are the ratings of the 4 analyists that currently disagree with Arun
- Josh Silverstein of "Wolfe Research" Initiated at Buy on, Thursday, June 10th, 2021
- Robert Koort of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $47 on, Wednesday, June 9th, 2021
- Matthew DeYoe of "B of A Securities" Initiated at Strong Buy and Held Target at $42 on, Thursday, May 20th, 2021
- David Coleman of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $40 on, Thursday, May 6th, 2021
Contributing Sources